RXST
RxSight, Inc.−$0.21 (4.38%) At close $4.59 · Today
☾After Hours −$0.35 (7.65%) Nov 3, 7:59 PM ET
About RXST
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
Company
- Headquarters
- Aliso Viejo, CA
- Employees
- 461 (2026)
- Listed
- Jul 30, 2021
- Exchange
- Nasdaq
- Website
- rxsight.com
- SEC industry
- Ophthalmic Goods
Financial summary
About
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
From company filings and market data · Not investment advice
Price data
52W range and average volume from daily bars (unadjusted, last 252 sessions).
Financials
Consensus estimates
The information provided is for educational purposes only and does not constitute investment advice. Past performance does not guarantee future results.